Newsletter | June 19, 2025

06.19.25 -- Multispecific Trial Supply Stability Hinges On CDMO Agility

SPONSOR

Did you know Catalent offers contracted analytical services?

With over 30+ years of experience, Catalent offers a comprehensive suite of orthogonal GMP analytical services for all biological modalities, from discovery to commercial phases. Our seasoned experts ensure exceptional on-time delivery and client satisfaction by providing tailored solutions to meet your unique needs—no matter the complexity, scale, or timeline. Watch our intro video to learn more about our capabilities!

FOCUS ON OUTSOURCING

Multispecific Trial Supply Stability Hinges On CDMO Agility

A conversation with Dr. Daniel Teper, Naya Therapeutics

Naya's CEO describes the dynamics of producing a complex therapeutic for clinical trials on another continent, and how choice of CDMO plays heavily into that strategy.

Building A Legacy In Sterile Injectables Through Strong CMO Synergy

White Paper | Pfizer CentreOne

Examine how a CMO can deliver significant value to drug developers by fostering successful outsourcing relationships, streamlining the path to market, and supporting demands.

Building The Next Therapeutic Modality With End-To-End Product Support

Article | By Nisa Renault and Daniel DeVido, FUJIFILM Diosynth Biotechnologies

Extracellular vesicles hold immense potential for treating diseases, owing to their natural biocompatibility and ability to carry a diverse arsenal of therapeutic molecules.

A Case For Adherent Cell Culture

Q&A | By Junwei Sun, Dr. Lucia Fernandez, and Matthew Ercolino, VintaBio

Review the importance of alternative approaches to viral vector production and the benefits of intensified adherent cell culture for improving efficiency, reducing costs, and accelerating development.

Effective Technology Transfer For Mammalian Derived Biopharmaceuticals

Webinar | Lonza

Gain the knowledge and tools necessary to facilitate successful technology transfer and accelerate the translation of your projects from bench to market.

Considerations When Choosing An Expression System For Your Product

Article | Cytovance Biologics

Discover how whether you’re trying to achieve speed and cost-effectiveness or higher yields and glycosylation capabilities, the right system can be tailored to meet the needs of each unique biologic.

3 Key Trends Shaping The CDMO Industry

Article | By Cory Lewis, INCOG BioPharma Services

Stay up to date on the future of CDMOs. Read about key trends such as adopting a customer-centric mindset, agile manufacturing, and embracing digitalization.

SPONSOR

Explore the latest biotech equipment and solutions — all online, wherever you are.

Don't miss the next Bio-Expo Live! This interactive, multi-day event is organized by stages of drug development and production, making it easy to find sessions tailored to your company's needs. Browse the full agenda and register for free to join the conversations most relevant to your work.

OUTSOURCING SOLUTIONS

•

Capacity Update April 2025: ADC - AGC Biologics

•

Advancing CRISPR-Based Therapeutic Development - Aldevron

•

The Journey To Safety Through Viral Clearance - MilliporeSigma

•

Particle Control In Biopharmaceuticals - Lonza

Connect With Bioprocess Online: